CONTINUOUS INFUSION OF LOW-DOSE 5-FLUOROURACIL AND RADIATION-THERAPY FOR POOR-PROGNOSIS SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX

被引：11

作者：

DRESCHER, CW

REID, GC

TERADA, K

ROBERTS, JA

HOPKINS, MP

PEREZTAMAYO, C

SCHOEPPEL, SL

机构：

[1] UNIV MICHIGAN,MED CTR,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,ANN ARBOR,MI 48109

[2] UNIV MICHIGAN,MED CTR,DEPT RADIAT ONCOL,ANN ARBOR,MI 48109

来源：

GYNECOLOGIC ONCOLOGY | 1992年 / 44卷 / 03期

关键词：

D O I：

10.1016/0090-8258(92)90047-M

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ten patients with squamous cell carcinoma of the cervix metastatic to periaortic lymph nodes were treated with external-beam radiation therapy and synchronous infusion of intravenous 5-fluorouracil (5-FU) chemotherapy at doses of 350 mg/m2/day. The overall response rate was 90% with four complete responses (CR) and five partial responses (PR). The median duration of response was 11.8 months for CRs and 3.6 months for PRs. Toxicity was tolerable, with gastrointestinal symptoms and myelosuppression being noted most frequently. No patient experienced life-threatening toxicity. Median survival was 7.6 months, with only one patient being alive and free of disease at 2 years. In this pilot study we were unable to demonstrate a beneficial effect of continuous infusion of low doses of 5-FU chemotherapy concurrent with radiation therapy when compared to conventional radiotherapy in patients with advanced squamous cell carcinoma of the cervix. © 1992.

引用

页码：227 / 230

页数：4

共 29 条

[1]

BARBOUNIS VP, 1989, ANTICANCER RES, V9, P33

[2] EXTENDED FIELD IRRADIATION IN THE TREATMENT OF PATIENTS WITH CERVICAL-CARCINOMA INVOLVING BIOPSY PROVEN PARA-AORTIC NODES [J].

BROOKLAND, RK ;

RUBIN, S ;

DANOFF, BF .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (10) :1875-1879

[3] PHARMACOLOGIC REQUIREMENTS FOR OBTAINING SENSITIZATION OF HUMAN-TUMOR CELLS-INVITRO TO COMBINED 5-FLUOROURACIL OR FTORAFUR AND X-RAYS [J].

BYFIELD, JE ;

CALABROJONES, P ;

KLISAK, I ;

KULHANIAN, F .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (11) :1923-1933

[4]

BYFIELD JE, 1980, CANCER-AM CANCER SOC, V45, P703, DOI 10.1002/1097-0142(19800215)45:4<703::AID-CNCR2820450415>3.0.CO

[5]

2-Q

[6] COMBINED TREATMENT OF RADIATION AND CIS-DIAMMINEDICHLOROPLATINUM(II) - A REVIEW OF EXPERIMENTAL AND CLINICAL-DATA [J].

DEWIT, L .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (03) :403-426

[7]

EISENBERGER M, 1990, CARBOPLATIN CURRENT

[8] CONCOMITANT 5-FLUOROURACIL, MITOMYCIN-C, AND RADIOTHERAPY FOR ADVANCED GYNECOLOGIC MALIGNANCIES [J].

EVANS, LS ;

KERSH, CR ;

CONSTABLE, WC ;

TAYLOR, PT .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (04) :901-906

[9] PHASE-I-II PILOT OF WHOLE ABDOMINAL RADIATION AND CONCOMITANT 5-FU AS AN ADJUVANT IN COLON CANCER - A SOUTHWEST ONCOLOGY GROUP-STUDY [J].

FABIAN, CJ ;

REDDY, E ;

JEWELL, W ;

TROWBRIDGE, AA ;

MCCRACKEN, D ;

VOGEL, S ;

GOODWIN, JW ;

FLETCHER, WS .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (04) :885-892

[10]

FU K, 1985, INT J RADIAT ONCOL, V5, P2123

← 1 2 3 →